Rabelink TJ - Search Results

1

Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.

Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ. Loomans CJ, et al. Among authors: rabelink tj. Diabetes. 2004 Jan;53(1):195-9. doi: 10.2337/diabetes.53.1.195. Diabetes. 2004. PMID: 14693715

2

Pitfalls of venous occlusion method for determination of capillary pressure in humans.

Braam B, Koomans HA, Rabelink TJ, Berckmans R. Braam B, et al. Among authors: rabelink tj. J Appl Physiol (1985). 1989 Feb;66(2):997-1002. doi: 10.1152/jappl.1989.66.2.997. J Appl Physiol (1985). 1989. PMID: 2708227

3

Enhanced natriuretic effect of atrial natriuretic factor during mineralocorticoid escape in humans.

Gaillard CA, Koomans HA, Rabelink TJ, Braam B, Boer P, Dorhout Mees EJ. Gaillard CA, et al. Among authors: rabelink tj. Hypertension. 1988 Oct;12(4):450-6. doi: 10.1161/01.hyp.12.4.450. Hypertension. 1988. PMID: 2971618

4

Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology.

Rabelink TJ, Kaasjager KA, Boer P, Stroes EG, Braam B, Koomans HA. Rabelink TJ, et al. Kidney Int. 1994 Aug;46(2):376-81. doi: 10.1038/ki.1994.284. Kidney Int. 1994. PMID: 7967349 Free article. Clinical Trial.

5

Plasma volume regulation: defences against edema formation (with special emphasis on hypoproteinemia).

Joles JA, Rabelink TJ, Braam B, Koomans HA. Joles JA, et al. Among authors: rabelink tj. Am J Nephrol. 1993;13(5):399-412. doi: 10.1159/000168654. Am J Nephrol. 1993. PMID: 8116692 Review.

6

5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia.

Verhaar MC, Wever RM, Kastelein JJ, van Dam T, Koomans HA, Rabelink TJ. Verhaar MC, et al. Among authors: rabelink tj. Circulation. 1998 Jan 27;97(3):237-41. doi: 10.1161/01.cir.97.3.237. Circulation. 1998. PMID: 9462523 Clinical Trial.

7

Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.

Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, Webb DJ. Verhaar MC, et al. Among authors: rabelink tj. Circulation. 1998 Mar 3;97(8):752-6. doi: 10.1161/01.cir.97.8.752. Circulation. 1998. PMID: 9498538

8

Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin.

Verhaar MC, Beutler JJ, Gaillard CA, Koomans HA, Fijnheer R, Rabelink TJ. Verhaar MC, et al. Among authors: rabelink tj. J Hypertens. 1998 Jan;16(1):45-50. doi: 10.1097/00004872-199816010-00008. J Hypertens. 1998. PMID: 9533416

9

Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition.

Verhagen AM, Rabelink TJ, Braam B, Opgenorth TJ, Gröne HJ, Koomans HA, Joles JA. Verhagen AM, et al. Among authors: rabelink tj. J Am Soc Nephrol. 1998 May;9(5):755-62. doi: 10.1681/ASN.V95755. J Am Soc Nephrol. 1998. PMID: 9596072

10

Endothelial function: strategies for early intervention.

Verhaar MC, Rabelink TJ. Verhaar MC, et al. Among authors: rabelink tj. Cardiovasc Drugs Ther. 1998 Apr;12 Suppl 1:125-34. doi: 10.1023/a:1007737412395. Cardiovasc Drugs Ther. 1998. PMID: 9642486 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

519 results

Search Page